# Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-profile-of-treatment-with-etoricoxib-120-mg-once-daily/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bernard R. Rubin,Robert Burton,Sandra Navarra,Joseph Antigua,John Londoño,Keith G. Pryhuber,Margaret Lund,Erluo Chen,Daryl K. Najarian,Richard A. Petruschke,Zafer E. Ozturk,Gregory P. Geba |
| Citations | 186 |
| DOI | 10.1002/art.20007 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.20007 |
| OpenAlex ID | https://openalex.org/W2071263587 |
| PMID | 14872504 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Sandra Navarra](https://scholariq.org/researchers/sandra-navarra/)

## Paper primary topic

- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)

## Paper topics

- [Gout, Hyperuricemia, Uric Acid](https://scholariq.org/topics/gout-hyperuricemia-uric-acid/)
- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Thyroid Disorders and Treatments](https://scholariq.org/topics/thyroid-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.